マイクロニードルドラッグデリバリーシステム市場規模、シェア、動向分析レポートタイプ別（固体、中空）、素材別（シリコン、金属）、用途別（皮膚科、ドラッグデリバリー）、地域別、セグメント予測、2023～2030年

マイクロニードルドラッグデリバリーシステム市場の成長と動向：

Grand View Research, Inc.の新しいレポートによると、世界のマイクロニードルドラッグデリバリーシステム市場規模は、2023年から2030年にかけて7.4%のCAGRを記録し、2030年には94億6,000万米ドルに達すると予測されています。

従来の皮下注射に代わるより安全な方法への需要の高まりと、低侵襲で痛みのない薬剤投与に対する意識の高まりが、マイクロニードル薬剤送達システムの市場成長を後押しすると期待されています。さらに、糖尿病患者の増加も市場の成長を後押しすると予想されています。例えば、2021年の世界保健機関（WHO）の推計によると、世界中で約4億6,300万人の成人が糖尿病を患っており、これは世界人口の9.3%に相当します。

マイクロニードルは、経口や経皮経路といった従来のドラッグデリバリー方法と比較して、いくつかの利点があります。マイクロニードルによるドラッグデリバリーは、特に水溶性の低い薬物や浸透性の低い薬物に対して、薬物の吸収、バイオアベイラビリティ、有効性を改善できることが研究により示されています。例えば、"Journal of Controlled Release"に掲載された研究では、マイクロニードルを用いたインスリンの経皮投与は、皮下注射よりも有効であることが示されています。

COVID-19のパンデミックは、マイクロニードルによるドラッグデリバリーに大きな影響を及ぼしました。パンデミックが市場に与えた大きな影響は、ワクチンデリバリーの需要が高まったことです。マイクロニードルは、その使いやすさ、低コスト、強い免疫反応を引き起こす可能性から、COVID-19ワクチンのデリバリー方法の候補として検討されてきました。パンデミックは、マイクロニードルを用いたワクチン送達システムの開発を加速し、複数の企業や学術機関がCOVID-19ワクチンパッチの開発に取り組んでいます。

しかし、パンデミックは世界のサプライチェーンを混乱させ、マイクロニードルドラッグデリバリーシステムの生産と流通に影響を及ぼしています。一部のメーカーは、原材料や部品の入手に課題を抱えており、その結果、供給不足と価格の上昇を招いています。

マイクロニードルドラッグデリバリーシステム市場レポートハイライト：

• 中空マイクロニードル分野は、ワクチンやホルモン療法患者の使用に最適とされているため、2022年に最大の収益シェアを占めました。
• 溶解型マイクロニードルセグメントは、挿入後にマイクロニードルを取り外す必要がなく、1ステップで済むため、予測期間中に最も速い速度で成長すると予想されます。
• 金属材料セグメントは2022年に最も高い収益シェアを占め、ステンレス鋼とチタンが最も頻繁に採用されている金属です。
• 用途別では、ドラッグデリバリー分野が2022年の市場を独占しました。
• ワクチン分野は、人々の間でワクチン接種に対する意識が高まっていることから、予測期間中に最も速い成長率を示すと予想されます。
• アジア太平洋は、中国とインドの新興経済圏に未開拓の機会が存在するため、予測期間中に最も速いCAGRで成長すると予測されています。

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • タイプ
  • 材料
  • 応用
  • 地域範囲
  • 推定・予測のタイムライン
• 調査手法
• 情報調達
  • 購入したデータベース
  • GVRの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査の詳細
    • 北米における一次面接のデータ
    • 欧州の一次面接データ
    • アジア太平洋地域の一次面接のデータ
    • ラテンアメリカの一次面接データ
    • MEAの一次面接データ
• 情報またはデータ分析
  • データ分析モデル
• 市場の形成と検証
• モデル詳細
  • 商品フロー解析（モデル1）
  • アプローチ1：商品フローのアプローチ
  • 出来高価格分析（モデル2）
  • アプローチ2：出来高価格分析
• 二次情報のリスト
• 一次情報のリスト
• 目的

第2章 エグゼクティブサマリー

• 市場の見通し
• セグメントの見通し
  • タイプの見通し
  • 素材の見通し
  • 用途の見通し
  • 地域別の見通し
• 競合考察

第3章 マイクロニードルドラッグデリバリーシステム市場の変数、動向および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し
• 普及と成長の見通しマッピング
• 業界のバリューチェーン分析
  • 償還の枠組み
• 市場力学
  • 市場促進要因の分析
    • 従来の皮下注射に代わるより安全な代替品への需要の高まり
    • 世界中で糖尿病患者が増加
    • 技術の進歩
  • 市場抑制要因分析
    • 承認された製品の数には限りがあります
    • マイクロニードルに関連する合併症/リスク
• マイクロニードルドラッグデリバリーシステム市場分析ツール
  • 業界分析- ポーターズ
    • サプライヤーの力
    • 買い手の交渉力
    • 交代の脅威
    • 新規参入者の脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治的情勢
    • 技術的情勢
    • 経済情勢
  • 主要取引と戦略的提携の分析
  • 市場参入戦略

第4章 マイクロニードルドラッグデリバリーシステム：タイプの推定・動向分析

• 定義と範囲
  • 固体
  • 中空
  • 溶解
  • コーティング
  • その他
• タイプ市場シェア、2022年および2030年
• セグメントダッシュボード
• タイプ別の世界のマイクロニードルドラッグデリバリーシステム市場の見通し
• 以下の市場規模、予測および傾向分析、2018年から2030年まで
  • 固体
  • 中空
  • 溶解
  • コーティング
  • その他

第5章 マイクロニードルドラッグデリバリーシステム：素材推定・動向分析

• 素材と範囲
  • ケイ素
  • 金属
  • ポリマー
  • その他
• 素材市場シェア、2022年および2030年
• セグメントダッシュボード
• 素材別の世界のマイクロニードルドラッグデリバリーシステム市場の見通し
• 以下の市場規模、予測および傾向分析、2018年から2030年まで
  • ケイ素
  • 金属
  • ポリマー
  • その他

第6章 マイクロニードルドラッグデリバリーシステム：アプリケーションの推定・動向分析

• 定義と範囲
  • 皮膚科
  • ドラッグデリバリー
  • 疼痛管理
  • がん治療
  • ワクチンの配達
  • その他
• アプリケーション市場シェア、2022年および2030年
• セグメントダッシュボード
• アプリケーション別の世界のマイクロニードルドラッグデリバリーシステム市場の見通し
• 以下の市場規模、予測および傾向分析、2018年から2030年まで
  • 皮膚科
  • ホルモンの配達
  • 疼痛管理
  • がん治療
  • ワクチンの配達
  • その他

第7章 マイクロニードルドラッグデリバリーシステム市場：地域推定・動向分析

• 地域市場シェア分析、2022年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 地域市場シェアと主要企業、2021年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ
• SWOT分析、要因別（政治・法律、経済・技術）
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ
• 市場規模、予測、量および傾向分析、2018年から2030年まで
• 北米
  • 市場推計・予測、2018～2030年（収益）
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • スウェーデン
  • ノルウェー
  • デンマーク
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• MEA
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業別最近の動向と影響分析
• 会社/競合の分類
  • イノベーター
• ベンダー情勢
  • List of key distributors and channel partners
  • Key customers
  • Key company market share analysis, 2021
  • Raphas
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Novartis International AG
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Becton, Dickinson and Company
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • B. Braun
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Nanopass technologies limited
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Termo
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Smiths Medical
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Cardinal Health
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • 3M
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み

List of Tables

• Table 1 List of Tables
• Table 2 List of Abbreviation
• Table 3 North America microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 4 North America microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 5 North America microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 6 North America microneedle drug delivery systems market, by region, 2018 - 2030 (USD Million)
• Table 7 U.S. microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 8 U.S. microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 9 U.S. microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 10 Canada microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 11 Canada microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 12 Canada microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 13 Europe microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 14 Europe microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 15 Europe microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 16 Europe microneedle drug delivery systems market, by region, 2018 - 2030 (USD Million)
• Table 17 Germany microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 18 Germany microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 19 Germany microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 20 UK microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 21 UK microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 22 UK microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 23 France microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 24 France microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 25 France microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 26 Italy microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 27 Italy microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 28 Italy microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 29 Spain microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 30 Spain microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 31 Spain microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 32 Sweden microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 33 Sweden microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 34 Sweden microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 35 Norway microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 36 Norway microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 37 Norway microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 38 Denmark microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 39 Denmark microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 40 Denmark microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 41 APAC microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 42 APAC microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 43 APAC microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 44 APAC microneedle drug delivery systems market, by region, 2018 - 2030 (USD Million)
• Table 45 China microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 46 China microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 47 China microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 48 Japan microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 49 Japan microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 50 Japan microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 51 India microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 52 India microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 53 India microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 54 Thailand microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 55 Thailand microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 56 Thailand microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 57 South Korea microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 58 South Korea microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 59 South Korea microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 60 Latin America microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 61 Latin America microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 62 Latin America microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 63 Latin America microneedle drug delivery systems market, by region, 2018 - 2030 (USD Million)
• Table 64 Brazil microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 65 Brazil microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 66 Brazil microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 67 Mexico microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 68 Mexico microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 69 Mexico microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 70 Argentina microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 71 Argentina microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 72 Argentina microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 73 Middle East and Africa microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 74 Middle East and Africa microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 75 Middle East and Africa microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 76 Middle East and Africa microneedle drug delivery systems market, by region, 2018 - 2030 (USD Million)
• Table 77 South Africa microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 78 South Africa microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 79 South Africa microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 80 Saudi Arabia microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 81 Saudi Arabia microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 83 UAE microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 84 UAE microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 85 UAE microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
• Table 86 Kuwait microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
• Table 87 Kuwait microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
• Table 88 Kuwait microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Microneedle Drug Delivery Systems : market outlook
• Fig. 9 Microneedle Drug Delivery Systems competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 Microneedle drug delivery systems market driver impact
• Fig. 15 Microneedle drug delivery systems market restraint impact
• Fig. 16 Microneedle drug delivery systems market strategic initiatives analysis
• Fig. 17 Microneedle drug delivery systems market: type movement analysis
• Fig. 18 Microneedle drug delivery systems market: type outlook and key takeaways
• Fig. 19 Solid market estimates and forecast, 2018 - 2030
• Fig. 20 Hollow market estimates and forecast, 2018 - 2030
• Fig. 21 Dissolving market estimates and forecast, 2018 - 2030
• Fig. 22 Coated market estimates and forecast, 2018 - 2030
• Fig. 23 Others market estimates and forecast, 2018 - 2030
• Fig. 24 Microneedle drug delivery systems market: material movement analysis
• Fig. 25 Microneedle drug delivery systems market: material outlook and key takeaways
• Fig. 26 Silicon market estimates and forecast, 2018 - 2030
• Fig. 27 Metal market estimates and forecast, 2018 - 2030
• Fig. 28 Polymer market estimates and forecast, 2018 - 2030
• Fig. 29 Others market estimates and forecast, 2018 - 2030
• Fig. 30 Microneedle drug delivery systems market: application movement analysis
• Fig. 31 Microneedle drug delivery systems market: application outlook and key takeaways
• Fig. 32 Dermatology market estimates and forecast, 2018 - 2030
• Fig. 33 Drug delivery market estimates and forecast, 2018 - 2030
• Fig. 34 Pain management market estimates and forecast, 2018 - 2030
• Fig. 35 Cancer therapy market estimates and forecast, 2018 - 2030
• Fig. 36 Vaccine delivery market estimates and forecast, 2018 - 2030
• Fig. 37 Others market estimates and forecast, 2018 - 2030
• Fig. 38 Global microneedle drug delivery systems market: regional movement analysis
• Fig. 39 Global microneedle drug delivery systems market: regional outlook and key takeaways
• Fig. 40 Global market share and leading players
• Fig. 41 North America market share and leading players
• Fig. 42 Europe market share and leading players
• Fig. 43 Asia Pacific market share and leading players
• Fig. 44 Latin America market share and leading players
• Fig. 45 Middle East & Africa market share and leading players
• Fig. 46 North America: SWOT
• Fig. 47 Europe SWOT
• Fig. 48 Asia Pacific SWOT
• Fig. 49 Latin America SWOT
• Fig. 50 MEA SWOT
• Fig. 51 North America, by country
• Fig. 52 North America
• Fig. 53 North America market estimates and forecast, 2018 - 2030
• Fig. 54 U.S.
• Fig. 55 U.S. market estimates and forecast, 2018 - 2030
• Fig. 56 Canada
• Fig. 57 Canada market estimates and forecast, 2018 - 2030
• Fig. 58 Europe
• Fig. 59 Europe. market estimates and forecast, 2018 - 2030
• Fig. 60 UK
• Fig. 61 UK market estimates and forecast, 2018 - 2030
• Fig. 62 Germany
• Fig. 63 Germany market estimates and forecast, 2018 - 2030
• Fig. 64 France
• Fig. 65 France market estimates and forecast, 2018 - 2030
• Fig. 66 Italy
• Fig. 67 Italy market estimates and forecast, 2018 - 2030
• Fig. 68 Spain
• Fig. 69 Spain market estimates and forecast, 2018 - 2030
• Fig. 70 Sweden
• Fig. 71 Sweden market estimates and forecast, 2018 - 2030
• Fig. 72 Norway
• Fig. 73 Norway market estimates and forecast, 2018 - 2030
• Fig. 74 Denmark
• Fig. 75 Denmark market estimates and forecast, 2018 - 2030
• Fig. 76 Asia Pacific
• Fig. 77 Asia Pacific market estimates and forecast, 2018 - 2030
• Fig. 78 China
• Fig. 79 China market estimates and forecast, 2018 - 2030
• Fig. 80 Japan
• Fig. 81 Japan market estimates and forecast, 2018 - 2030
• Fig. 82 India
• Fig. 83 India market estimates and forecast, 2018 - 2030
• Fig. 84 Australia
• Fig. 85 Australia market estimates and forecast, 2018 - 2030
• Fig. 86 Thailand
• Fig. 87 Thailand market estimates and forecast, 2018 - 2030
• Fig. 88 South Korea
• Fig. 89 South Korea market estimates and forecast, 2018 - 2030
• Fig. 90 Latin America
• Fig. 91 Latin America market estimates and forecast, 2018 - 2030
• Fig. 92 Brazil
• Fig. 93 Brazil market estimates and forecast, 2018 - 2030
• Fig. 94 Mexico
• Fig. 95 Mexico market estimates and forecast, 2018 - 2030
• Fig. 96 Argentina
• Fig. 97 Argentina market estimates and forecast, 2018 - 2030
• Fig. 98 Middle East and Africa
• Fig. 99 Middle East and Africa. market estimates and forecast, 2018 - 2030
• Fig. 100 Saudi Arabia
• Fig. 101 Saudi Arabia market estimates and forecast, 2018 - 2030
• Fig. 102 South Africa
• Fig. 103 South Africa market estimates and forecast, 2018 - 2030
• Fig. 104 UAE
• Fig. 105 UAE market estimates and forecast, 2018 - 2030
• Fig. 106 Kuwait
• Fig. 107 Kuwait market estimates and forecast, 2018 - 2030
• Fig. 108 Participant categorization - Microneedle Drug Delivery Systems market
• Fig. 109 Market share of key market players - Microneedle drug delivery systems market

Microneedle Drug Delivery Systems Market Growth & Trends:

The global microneedle drug delivery systems market size is expected to reach USD 9.46 billion by 2030, registering a CAGR of 7.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growing demand for safer alternatives to conventional hypodermic injection and increasing awareness about minimally invasive and pain-free administration of drugs is expected to boost the market growth for microneedle drug delivery systems. Furthermore, increasing cases of diabetes are also expected to boost the market growth. For instance, as per the estimates of the World Health Organization (WHO) in 2021, approximately 463 million adults were living with diabetes, worldwide, representing 9.3% of the global population.

Microneedles offer several advantages over traditional drug delivery methods, such as oral or transdermal routes. Studies have shown that drug delivery by microneedles can improve drug absorption, bioavailability and efficacy, especially for drugs with poor water solubility or low permeability. For instance, a study published in "Journal of Controlled Release" showed that transdermal delivery of insulin using microneedles was more effective than subcutaneous injection.

The COVID-19 pandemic had a significant impact on drug delivery by microneedles. The major impact of the pandemic on the market was the increased demand for vaccine delivery. Microneedles have been explored as a potential delivery method for the COVID-19 vaccines due to their ease of use, low cost, and potential to induce a strong immune response. The pandemic has accelerated development of the microneedle-based vaccine delivery systems, with several companies and academic institutions working on COVID-19 vaccine patches.

However, the pandemic has also disrupted global supply chains, which has affected the production and distribution of microneedle-based drug delivery systems. Some manufacturers have faced challenges in obtaining raw materials and components, which has resulted in supply shortages and increased prices.

Microneedle Drug Delivery Systems Market Report Highlights:

• The hollow microneedle segment accounted for the largest revenue share in 2022, since they are considered ideal for the use of vaccine and hormonal therapy patients

• Dissolving microneedle segment is expected to grow at the fastest rate during the forecast period, as it only requires one step, the microneedle needs not be removed after insertion

• The metal material segment accounted for the highest revenue share in 2022; stainless steel and titanium are the most frequently employed metals

• By application, drug delivery segment dominated the market in 2022

• The vaccine segment is expected to experience the fastest growth rate during the forecast period due to the increased awareness of vaccination among populations

• Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period due to the presence of untapped opportunities in the emerging economies of China and India

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Material
  • 1.1.3. Application
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1.1. Commodity flow analysis (Model 1)
  • 1.6.1.2. Approach 1: Commodity flow approach
  • 1.6.1.3. Volume price analysis (Model 2)
  • 1.6.1.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Material outlook
  • 2.2.3. Application outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Microneedle Drug Delivery Systems Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. The increasing demand for safer substitute to conventional hypodermic injections
    • 3.4.1.2. Increase in diabetic cases across the globe
    • 3.4.1.3. Technological advancements
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. Limited number of approved products
    • 3.4.2.2. Complications/risks associated with microneedles
• 3.5. Microneedle Drug Delivery Systems Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
  • 3.5.3. Major Deals & Strategic Alliances Analysis
  • 3.5.4. Market Entry Strategies

Chapter 4. Microneedle Drug Delivery Systems : Type Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Solid
  • 4.1.2. Hollow
  • 4.1.3. Dissolving
  • 4.1.4. Coated
  • 4.1.5. Others
• 4.2. Type Market Share, 2022 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Microneedle Drug Delivery Systems Market by Type Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Solid
    • 4.5.1.1. Solid market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Hollow
    • 4.5.2.1. Hollow market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.3. Dissolving
    • 4.5.3.1. Dissolving market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.4. Coated
    • 4.5.4.1. Coated market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Microneedle Drug Delivery Systems : Material Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Silicon
  • 5.1.2. Metal
  • 5.1.3. Polymer
  • 5.1.4. Others
• 5.2. Material Market Share, 2022 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Microneedle Drug Delivery Systems Market by Material Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Silicon
    • 5.5.1.1. Silicon market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Metal
    • 5.5.2.1. Metal market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.3. Polymer
    • 5.5.3.1. Polymer market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.4. Others
    • 5.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Microneedle Drug Delivery Systems : Application Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Dermatology
  • 6.1.2. Drug delivery
  • 6.1.3. Pain management
  • 6.1.4. Cancer therapy
  • 6.1.5. Vaccine delivery
  • 6.1.6. Others
• 6.2. Application Market Share, 2022 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Microneedle Drug Delivery Systems Market by Application Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030for the following
  • 6.5.1. Dermatology
    • 6.5.1.1. Dermatology market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Hormone delivery
    • 6.5.2.1. Hormone delivery market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Pain management
    • 6.5.3.1. Pain management market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.4. Cancer therapy
    • 6.5.4.1. Cancer therapy market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.5. Vaccine delivery
    • 6.5.5.1. Vaccine delivery market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.6. Others
    • 6.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Microneedle Drug Delivery Systems Market: Regional Estimates & Trend Analysis

• 7.1. Regional market share analysis, 2022 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Regional Market Share and Leading Players, 2021
  • 7.4.1. North America
  • 7.4.2. Europe
  • 7.4.3. Asia Pacific
  • 7.4.4. Latin America
  • 7.4.5. Middle East and Africa
• 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
  • 7.5.1. North America
  • 7.5.2. Europe
  • 7.5.3. Asia Pacific
  • 7.5.4. Latin America
  • 7.5.5. Middle East and Africa
• 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030
• 7.7. North America
  • 7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.7.2. U.S.
    • 7.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.7.3. Canada
    • 7.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
• 7.8. Europe
  • 7.8.1. UK
    • 7.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.8.2. Germany
    • 7.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.8.3. France
    • 7.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.8.4. Italy
    • 7.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.8.5. Spain
    • 7.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.8.6. Sweden
    • 7.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.8.7. Norway
    • 7.8.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.8.8. Denmark
    • 7.8.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
• 7.9. Asia Pacific
  • 7.9.1. China
    • 7.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.9.2. Japan
    • 7.9.2.1. Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
  • 7.9.3. India
    • 7.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.9.4. Australia
    • 7.9.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.9.5. Thailand
    • 7.9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.9.6. South Korea
    • 7.9.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
• 7.10. Latin America
  • 7.10.1. Brazil
    • 7.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.10.2. Mexico
    • 7.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.10.3. Argentina
    • 7.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
• 7.11. MEA
  • 7.11.1. Saudi Arabia
    • 7.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.11.2. South Africa
    • 7.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.11.3. UAE
    • 7.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.11.4. Kuwait
    • 7.11.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2021
  • 8.3.4. Raphas
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Novartis International AG
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Becton, Dickinson and Company
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. B. Braun
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Nanopass technologies limited
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Termo
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Smiths Medical
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Cardinal Health
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. 3M
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives